Delivery Order SPE2DB20D1004-SPE2DB22FF0V1
Award Date 1/4/22
Potential Completion Date 1/5/22
Potential Value $20K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Stelara 90 mg/ml syringes. The $19,167.87 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate...
- This federal contract award, valued at $48,403.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty medication. This is a firm fixed-price delivery order contract with a period of performance ending on January 31, 2024. The contract was awarded on an unrestricted, full and open competition basis with no set-aside designation. Amerisourcebergen Drug Corp is a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $12,568.40, is for the delivery of STELARA 90 MG/ML SYRINGE/ML medication and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 45 mg/0.5 ml syringes. The contract, valued at $3,281.21, is a firm fixed-price delivery order with a completion date of March 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,680.82 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 7, 2022, with a completion date of September 8, 2022. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $32,477.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm-fixed price delivery order contract with a completion date of May 1, 2024. The contract was awarded on April 30, 2024, and does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $5,061.64, was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
- This federal contract award, valued at $16,915.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product, with a completion date of February 13, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of STELARA 90 MG/ML syringes. The fixed-price contract, valued at $16,662.07, has an ultimate completion date of April 25, 2023. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...